The Effect of Combined Exposure of 900 MHz Radiofrequency Fields and Doxorubicin in HL-60 Cells

Human promyelocytic leukemia HL-60 cells were pre-exposed to non-ionizing 900 MHz radiofrequency fields (RF) at 12 µW/cm(2) power density for 1 hour/day for 3 days and then treated with a chemotherapeutic drug, doxorubicin (DOX, 0.125 mg/L). Several end-points related to toxicity, viz., viability, a...

Descripción completa

Detalles Bibliográficos
Autores principales: Jin, Zongda, Zong, Chunyan, Jiang, Bingcheng, Zhou, Zhen, Tong, Jian, Cao, Yi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3460948/
https://www.ncbi.nlm.nih.gov/pubmed/23029402
http://dx.doi.org/10.1371/journal.pone.0046102

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3460948/
https://www.ncbi.nlm.nih.gov/pubmed/23029402
http://dx.doi.org/10.1371/journal.pone.0046102

Ejemplares similares